Due to the use of immunosuppressive therapy in patients with respiratory failure in the course of SARS-CoV-2 infection, the diagnostic value of proinflammatory markers such as PCT in the early detection of secondary bacterial infections may be limited. This evidence concerns the gene CALCA and bacterial infectious disease.